4.7 Article

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis

Sara Suliman et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Infectious Diseases

Initiation and completion rates for latent tuberculosis infection treatment: a systematic review

Andreas Sandgren et al.

BMC INFECTIOUS DISEASES (2016)

Article Medicine, General & Internal

TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions

R. M. G. J. Houben et al.

BMC MEDICINE (2016)

Article Medicine, General & Internal

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

Daniel E. Zak et al.

LANCET (2016)

Article Multidisciplinary Sciences

Understanding the incremental value of novel diagnostic tests for tuberculosis

Nimalan Arinaminpathy et al.

NATURE (2015)

Article Multidisciplinary Sciences

Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings

Rein M. G. J. Houben et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Medicine, General & Internal

Tuberculosis preventive therapy: An underutilised strategy to reduce individual risk of TB and contribute to TB control

G. J. Churchyard et al.

SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2014)

Review Public, Environmental & Occupational Health

Prospects for Tuberculosis Elimination

Christopher Dye et al.

ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)

Article Cell Biology

Community-Wide Isoniazid Preventive Therapy Drives Drug-Resistant Tuberculosis: A Model-Based Analysis

Harriet L. Mills et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Review Medicine, General & Internal

Xpert (R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review)

Karen R. Steingart et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)

Article Medicine, General & Internal

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Timothy R. Sterling et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Medicine, General & Internal

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update

Madhukar Pai et al.

ANNALS OF INTERNAL MEDICINE (2008)